iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: Dec 5, 2025, 4:00 PM EST
1.200
0.00 (0.02%)
After-hours: Dec 5, 2025, 7:52 PM EST
iBio, Inc. Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for iBio, Inc. stock ranges from a low of $2.00 to a high of $6.00. The average analyst price target of $4.50 forecasts a 275.00% increase in the stock price over the next year.
Price Target: $4.50 (+275.00%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 21, 2025.
Analyst Ratings
The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +316.67% | Oct 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $2 | Buy | Initiates | $2 | +66.67% | Oct 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | Jun 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | May 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +316.67% | May 5, 2025 |
Financial Forecast
Revenue This Year
153.00K
from 400.00K
Decreased by -61.75%
Revenue Next Year
170.00K
from 153.00K
Increased by 11.11%
EPS This Year
-0.44
from -1.75
EPS Next Year
-0.30
from -0.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 525,000 | 525,000 | |||
| Avg | 153,000 | 170,003 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 31.3% | 243.1% | |||
| Avg | -61.8% | 11.1% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.29 | -0.19 | |||
| Avg | -0.44 | -0.30 | |||
| Low | -0.80 | -0.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.